徐兵河, 祖健. 贝伐单抗联合紫杉醇与单用紫杉醇对转移性乳腺癌的疗效及安全性比较[J]. 循证医学, 2008, 8(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2008.03.003
    引用本文: 徐兵河, 祖健. 贝伐单抗联合紫杉醇与单用紫杉醇对转移性乳腺癌的疗效及安全性比较[J]. 循证医学, 2008, 8(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2008.03.003
    XU Bing-he, ZU Jian. Paclitaxel Plus Bevacizumab Verbxis Paclitaxel Alone for Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2008.03.003
    Citation: XU Bing-he, ZU Jian. Paclitaxel Plus Bevacizumab Verbxis Paclitaxel Alone for Metastatic Breast Cancer[J]. Journal of Evidence-Based Medicine, 2008, 8(3): 135-137. DOI: 10.3969/j.issn.1671-5144.2008.03.003

    贝伐单抗联合紫杉醇与单用紫杉醇对转移性乳腺癌的疗效及安全性比较

    Paclitaxel Plus Bevacizumab Verbxis Paclitaxel Alone for Metastatic Breast Cancer

    /

    返回文章
    返回